Grant Medical Center was established in 1900 in downtown Columbus, Ohio as the second member hospital of OhioHealth, a not-for-profit, faith-based healthcare system. Grant Medical Center is a Level I Trauma Center.

There are 434 beds in Grant Medical Center.

During the past decade, Grant Medical Center conducted 134 clinical trials. In the 10-year time frame, 134 clinical trials started and 120 clinical trials were completed, i.e. on average, 89.6% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 67 clinical trials were completed. i.e. 128.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Grant Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 128 trials, followed by "SWOG Cancer Research Network" with 38 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "GOG Foundation" with 12 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grant Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 100 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Grant Medical Center" are "Recurrent Breast Carcinoma" (12 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Breast Cancer AJCC v6 and v7" (10 trials) and "Stage IV Lung Cancer AJCC v8" (10 trials). Many other conditions were trialed in "Grant Medical Center" in a lesser frequency.

Most popular intervention types in "Grant Medical Center" are "Drug" (189 trials), "Other" (154 trials), "Biological" (104 trials), "Procedure" (53 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (86 trials), "Quality-of-Life Assessment" (68 trials), "Questionnaire Administration" (36 trials), "Paclitaxel" (34 trials) and "Carboplatin" (32 trials). Other intervention names were less common.

The vast majority of trials in "Grant Medical Center" are 189 trials for "All" genders, 52 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Grant Medical Center". undefined are not yet recruiting, 45 are recruiting, 111 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Grant Medical Center, 2 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Grant Medical Center, 9 "Phase 1" clinical trials were conducted, 109 "Phase 2" clinical trials and 120 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".